As of Nov 15
| +11.05 / +14.50%|
The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 110.00, with a high estimate of 110.00 and a low estimate of 110.00. The median estimate represents a +26.05% increase from the last price of 87.27.
The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.